Demir M, Demir C, Keçeoglu S Relationship between serum bilirubin concentration and nondipper hypertension. Int J Clin Exp Med. 2014 May 15;7(5):1454-8. eCollection 2014.
Flammer J, Mozaffarieh M What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol. 2007 Nov;52 Suppl 2:S162-73. Review.
Henry E, Newby DE, Webb DJ, O'Brien C Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1710-4.
Kapitulnik J Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol. 2004 Oct;66(4):773-9. Epub 2004 Jul 21. Review.
Liao SL The role of bilirubin and phototherapy in the oxidative/antioxidant balance. Pediatr Neonatol. 2015 Apr;56(2):77-8. doi: 10.1016/j.pedneo.2015.01.001. Epub 2015 Jan 22.
Mallick J, Devi L, Malik PK, Mallick J Update on Normal Tension Glaucoma. J Ophthalmic Vis Res. 2016 Apr-Jun;11(2):204-8. doi: 10.4103/2008-322X.183914. Review.
Tanindi A, Erkan AF, Alhan A, Töre HF Arterial stiffness and central arterial wave reflection are associated with serum uric acid, total bilirubin, and neutrophil-to-lymphocyte ratio in patients with coronary artery disease. Anatol J Cardiol. 2015 May;15
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013. Epub 20
Wu TW, Fung KP, Wu J, Yang CC, Weisel RD Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol. 1996 Mar 22;51(6):859-62.
Yuki K, Murat D, Kimura I, Ohtake Y, Tsubota K Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2010 Feb;248(2):243-8. doi: 10.1007/s00417-009-1183-6. Epub 2009 Sep 8.
Reduced Serum Bilirubin Levels in Patients With Normal-tension Glaucoma
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
